Clinical Research, Parkinson's Disease
Cognition Therapeutics, Inc.
Who We Are
Cognition Therapeutics, Inc. is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. Cognition’s mission is to stop the unrelenting progression of neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and dementia with Lewy bodies (DLB), and by doing so alter the impact of the societal tsunami of these fatal diseases.